Semaglutide is a GLP-1 receptor agonist peptide originally developed for glycemic regulation in type 2 diabetes research. It has gained significant attention for its powerful effects on appetite suppression, glucose control, and metabolic enhancement. Semaglutide supports substantial fat loss without muscle catabolism.
In research settings, Semaglutide has been shown to delay gastric emptying, promote insulin sensitivity, and suppress appetite via central nervous system pathways. It is ideal for studies focused on obesity, insulin resistance, and long-term weight management models.
Key Characteristics
| Feature | Description |
|---|---|
| Compound | Semaglutide |
| Form | Lyophilized Peptide |
| Strength | 2mg per vial |
| Primary Use | Fat loss, glucose regulation, appetite suppression |
| Benefit | Reduces body fat while maintaining lean mass |
Benefits
- Powerful appetite suppression and calorie control
- Supports long-term fat loss without stimulants
- Improves insulin sensitivity and glucose uptake
- Reduces risk factors related to obesity and metabolic syndrome
- Well tolerated in long-term research protocols
Reviews
There are no reviews yet.